• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于描述具有持久聚合物基质涂层的药物洗脱支架药物释放行为的理论模型。

A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating.

机构信息

Peripheral Combination Devices, Abbott Vascular, Santa Clara, California, USA.

出版信息

J Biomed Mater Res A. 2012 Jan;100(1):120-4. doi: 10.1002/jbm.a.33246. Epub 2011 Oct 14.

DOI:10.1002/jbm.a.33246
PMID:21997889
Abstract

The time-dependent local drug delivery from drug-eluting stents (DES) plays a critical role in reducing restenosis in intravascular stenting. To better understand the basic mechanism of drug release for certain polymer-drug-coated DES platforms, a cylindrical diffusion model was applied successfully to quantitatively describe the experimental drug release data of Dynalink-E in vitro and in vivo. The results showed that the profiles of Dynalink-E everolimus release could be controlled by such characteristic parameters as coating thickness and diffusion coefficient. The model could be used to quantitatively characterize the drug release profiles and IVIV correlations.

摘要

药物洗脱支架(DES)的时变局部药物释放在减少血管内支架再狭窄方面起着关键作用。为了更好地了解某些聚合物-药物涂层 DES 平台的药物释放基本机制,成功地应用了圆柱形扩散模型来定量描述 Dynalink-E 的体外和体内药物释放数据。结果表明,Dynalink-E 依维莫司释放的曲线可以通过涂层厚度和扩散系数等特征参数来控制。该模型可用于定量描述药物释放曲线和 IVIV 相关性。

相似文献

1
A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating.一种用于描述具有持久聚合物基质涂层的药物洗脱支架药物释放行为的理论模型。
J Biomed Mater Res A. 2012 Jan;100(1):120-4. doi: 10.1002/jbm.a.33246. Epub 2011 Oct 14.
2
A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.一种用于预测生物可持久药物洗脱支架涂层药物释放的数学模型。
J Biomed Mater Res A. 2008 Nov;87(2):487-93. doi: 10.1002/jbm.a.31787.
3
Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.药物洗脱可生物降解聚合物涂层控释支架的制备及其体外释放曲线
Colloids Surf B Biointerfaces. 2009 Oct 15;73(2):199-206. doi: 10.1016/j.colsurfb.2009.05.016. Epub 2009 May 27.
4
In vitro and in vivo performance of a dual drug-eluting stent (DDES).一种双重药物洗脱支架(DDES)的体内外性能。
Biomaterials. 2010 May;31(15):4382-91. doi: 10.1016/j.biomaterials.2010.01.147. Epub 2010 Feb 26.
5
Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.新型生物可吸收的水杨酸基聚合物作为药物洗脱支架涂层。
Catheter Cardiovasc Interv. 2008 Aug 1;72(2):186-94. doi: 10.1002/ccd.21607.
6
Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.用于基于支架的局部药物递送的雷帕霉素类似物。依维莫司和他克莫司洗脱支架。
Herz. 2004 Mar;29(2):162-6. doi: 10.1007/s00059-004-2556-6.
7
Study of drug-eluting coating on metal coronary stent.药物洗脱涂层金属冠状动脉支架的研究。
Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):1476-80. doi: 10.1016/j.msec.2012.12.049. Epub 2012 Dec 23.
8
Impact of different tissue-simulating hydrogel compartments on in vitro release and distribution from drug-eluting stents.不同组织模拟水凝胶隔室对药物洗脱支架体外释放和分布的影响。
Eur J Pharm Biopharm. 2014 Aug;87(3):570-8. doi: 10.1016/j.ejpb.2014.04.010. Epub 2014 May 4.
9
Experimental efficacy of an everolimus eluting cobalt chromium stent.依维莫司洗脱钴铬合金支架的实验疗效
Catheter Cardiovasc Interv. 2006 Jul;68(1):97-103. doi: 10.1002/ccd.20769.
10
Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating.聚合物涂层中疏水性药物释放模型的参数估计方法。
J Control Release. 2010 Mar 19;142(3):474-82. doi: 10.1016/j.jconrel.2009.11.021. Epub 2009 Dec 1.

引用本文的文献

1
Doxycycline-Eluting Core-Shell Type Nanofiber-Covered Trachea Stent for Inhibition of Cellular Metalloproteinase and Its Related Fibrotic Stenosis.用于抑制细胞金属蛋白酶及其相关纤维化狭窄的强力霉素洗脱核壳型纳米纤维覆盖气管支架
Pharmaceutics. 2019 Aug 19;11(8):421. doi: 10.3390/pharmaceutics11080421.
2
Modelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary Stents.模拟动脉粥样硬化对冠状动脉支架药物释放和分布的影响。
Ann Biomed Eng. 2016 Feb;44(2):477-87. doi: 10.1007/s10439-015-1456-7. Epub 2015 Sep 18.
3
A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion.
一种用于聚乳酸-羟基乙酸共聚物(PLGA)可生物降解支架涂层中药物释放的机理模型,该模型结合了聚合物的降解和侵蚀。
J Biomed Mater Res A. 2015 Jul;103(7):2269-79. doi: 10.1002/jbm.a.35357. Epub 2014 Nov 12.
4
Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy.载有他克莫司的球囊治疗中组织摄取和滞留的机制。
Circulation. 2013 May 21;127(20):2047-55. doi: 10.1161/CIRCULATIONAHA.113.002051. Epub 2013 Apr 12.